Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04610-4 Two early clinical studies of selective KRASG12D inhibitors show encouraging activity in advanced cancers with G12D mutations, signaling a transformative change in the treatment landscape for RAS-driven cancers with potential applications across tumor types and stages of disease. Read More
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8 In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound. Read More
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04609-x An autonomous clinical AI agent enhances decision-making through on-premise deployment and reliability metrics, achieving high diagnostic accuracy and selective autonomy. Read More
First in a series on probabilistic forecasting for physical signals. Next: what happens when you roll the forecast forward more than one step. The post Your Model’s MSE Is Lying to You appeared first on Towards Data Science. Read More
When Codex is the right shape for the problem, when Claude Code is, and how I split 5 specialist agents between them on dense AI capacity work. The post When to Use One Model and When to Use a Team of Agents appeared first on Towards Data Science. Read More